Toshinari Ohara.
president
biology
BioMolTech
United States of America
Biography
Toshinari Ohara is currently the Chief Executive Officer at Sekisui XenoTech. Toshi received a Ph.D. in Pharmaceutical Sciences from Nagoya City University in 1991. Toshi was previously part of the management team at XenoTech from 2009 to 2013 before returning to Sekisui Medical Co. to serve as the Head of the R&D division at the ADME & Tox Research Institute. Most recently, Toshi served as the General Manager of Business Planning Department for Sekisui's Drug Development Solutions Division
Research Interest
Research intrest in Biotechnology